HCR Wealth Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.47M | Sell |
11,202
-201
| -2% | -$55.6K | 0.22% | 71 |
|
|
2026
Q1 | $3.37M | Sell |
11,403
-165
| -1% | -$49K | 0.35% | 53 |
|
|
2025
Q4 | $3.16M | Buy |
11,568
+416
| +4% | +$113K | 0.31% | 55 |
|
|
2025
Q3 | $2.96M | Buy |
11,152
+580
| +5% | +$158K | 0.31% | 54 |
|
|
2025
Q2 | $2.91M | Buy |
10,572
+420
| +4% | +$114K | 0.34% | 50 |
|
|
2025
Q1 | $2.69M | Sell |
10,152
-111
| -1% | -$27.4K | 0.35% | 49 |
|
|
2024
Q4 | $2.38M | Buy |
10,263
+4
| +0% | +$920 | 0.3% | 55 |
|
|
2024
Q3 | $2.26M | Buy |
10,259
+140
| +1% | +$29K | 0.3% | 53 |
|
|
2024
Q2 | $1.99M | Buy |
10,119
+138
| +1% | +$28.5K | 0.28% | 58 |
|
|
2024
Q1 | $2.15M | Buy |
9,981
+104
| +1% | +$21.8K | 0.33% | 55 |
|
|
2023
Q4 | $2.08M | Buy |
9,877
+806
| +9% | +$172K | 0.33% | 55 |
|
|
2023
Q3 | $1.82M | Sell |
9,071
-1,931
| -18% | -$384K | 0.4% | 48 |
|
|
2023
Q2 | $2.04M | Sell |
11,002
-118
| -1% | -$21.8K | 0.38% | 55 |
|
|
2023
Q1 | $2.13M | Buy |
11,120
+305
| +3% | +$55.2K | 0.42% | 47 |
|
|
2022
Q4 | $1.86M | Sell |
10,815
-283
| -3% | -$49.2K | 0.39% | 56 |
|
|
2022
Q3 | $1.97M | Sell |
11,098
-379
| -3% | -$74.9K | 0.42% | 51 |
|
|
2022
Q2 | $2.35M | Sell |
11,477
-289
| -2% | -$61.3K | 0.47% | 45 |
|
|
2022
Q1 | $2.8M | Sell |
11,766
-1,022
| -8% | -$240K | 0.46% | 48 |
|
|
2021
Q4 | $2.92M | Sell |
12,788
-378
| -3% | -$83.2K | 0.45% | 48 |
|
|
2021
Q3 | $2.55M | Buy |
13,166
+481
| +4% | +$97.4K | 0.42% | 57 |
|
|
2021
Q2 | $2.7M | Buy |
12,685
+409
| +3% | +$86.4K | 0.47% | 47 |
|
|
2021
Q1 | $2.51M | Sell |
12,276
-918
| -7% | -$181K | 0.5% | 42 |
|
|
2020
Q4 | $2.4M | Buy |
13,194
+971
| +8% | +$165K | 0.5% | 35 |
|
|
2020
Q3 | $2.04M | Buy |
12,223
+1,394
| +13% | +$235K | 0.47% | 41 |
|
|
2020
Q2 | $1.82M | Buy |
10,829
+542
| +5% | +$97.2K | 0.43% | 39 |
|
|
2020
Q1 | $1.78M | Sell |
10,287
-280
| -3% | -$55.7K | 0.51% | 32 |
|
|
2019
Q4 | $2.12M | Buy |
10,567
+505
| +5% | +$104K | 0.51% | 36 |
|
|
2019
Q3 | $2.12M | Buy |
10,062
+754
| +8% | +$158K | 0.7% | 30 |
|
|
2019
Q2 | $1.81M | Sell |
9,308
-363
| -4% | -$66.9K | 0.51% | 39 |
|
|
2019
Q1 | $1.59M | Sell |
9,671
-597
| -6% | -$106K | 0.46% | 44 |
|
|
2018
Q4 | $1.93M | Buy |
+10,268
| New | +$1.9M | 0.62% | 30 |
|
|
2018
Q3 | – | Sell |
-7,550
| Closed | -$1.24M | – | 160 |
|
|
2018
Q2 | $1.24M | Buy |
7,550
+1,270
| +20% | +$207K | 0.41% | 59 |
|
|
2018
Q1 | $1.02M | Buy |
6,280
+4,542
| +261% | +$723K | 0.35% | 72 |
|
|
2017
Q4 | $254K | Hold |
1,738
| – | – | 0.09% | 143 |
|
|
2017
Q3 | $236K | Hold |
1,738
| – | – | 0.1% | 141 |
|
|
2017
Q2 | $218K | Hold |
1,738
| – | – | 0.11% | 128 |
|
|
2017
Q1 | $206K | Hold |
1,738
| – | – | 0.11% | 141 |
|
|
2016
Q4 | $200K | Buy |
+1,738
| New | +$193K | 0.11% | 139 |
|
Other funds holding CME
PAM
SP
HCM
CF
OIAM
SI
AAMU
HCR Wealth Advisors's CME Position: Q2 2026 in Review
HCR Wealth Advisors reduced its CME Group (CME) stake by 1.8% in Q2 2026, selling an estimated $55.6K and leaving 11,202 shares worth $2.47M. The position accounts for 0.22% of the portfolio, ranked #71.
HCR Wealth Advisors first reported a position in CME in Q4 2016 and has held it in 38 quarters since. The position peaked at $3.37M in Q1 2026. 311 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- HCR Wealth Advisors held 11,202 shares of CME Group worth $2.47M as of Q2 2026.
- HCR Wealth Advisors sold 201 CME Group shares in Q2 2026, an estimated $55.6K.
- CME Group made up 0.22% of HCR Wealth Advisors's portfolio in Q2 2026, its #71 holding.
- HCR Wealth Advisors first reported a position in CME Group in Q4 2016 and has held it in 38 quarters since.
- HCR Wealth Advisors's CME Group position peaked at $3.37M in Q1 2026.
- 311 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on HCR Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.